ClinicalTrials.gg
Not yet recruitingNCT05788250Updated Apr 2, 2024

RC Repair Versus Subacromial Balloon Spacer in Older Adults

An interventional study of Subacromial spacer implantation and Rotator cuff repair in Rotator Cuff Tears, sponsored by Panam Clinic. Not yet recruiting. Open to participants aged 70 Years and older. Per ClinicalTrials.gov, last updated 2024-04-02.

Sponsored by Panam Clinic · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
70 Years and older
Sex
All
01

Study summary

The purpose of this pilot study is to assess the feasibility of a full randomized trial design.

Read the detailed description

The feasibility objectives are:

  1. Recruitment

    1. To establish an estimate of the proportion of patients screened who are eligible for inclusion, and of those, the proportion who consent.
    2. To establish an estimate of the proportion of eligible patients with medium/large tears versus massive tears.
  2. Surgery -to confirm agreement among surgeons regarding the protocol's standardized surgical techniques of both groups.

Clinical objectives for observational purposes only are as follows:

  1. Patient reported and clinical outcomes.
  2. Number of "failures" in each group (defined as additional surgery and/or having \<12% improvement in SANE score from baseline).
02

Conditions studied

  • Rotator Cuff Tears

Browse trials for

Keywords

  • rotator cuff repair
  • subacromial spacer
  • older adults
03

In context

Rotator Cuff Injuries

631 studies on the registry are indexed under Rotator Cuff Injuries; 156 are open to participants now.

This study's planned enrollment of 32 is below the median of 60 across 456 interventional studies indexed under Rotator Cuff Injuries.

Browse Rotator Cuff Injuries studies →

Lead sponsor

Panam Clinic is the lead sponsor of 16 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
70 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 70 years of age or older
  • clinical and radiological diagnosis of a full thickness supraspinatus (or larger) RC tear >2cm or more than 1 full tendon
  • ongoing symptoms after 3 months of physiotherapy
  • a tendon amenable to partial or complete repair (as determined by pre-operative MRI)
  • absence glenohumeral arthritis (Hamada \< 3)
  • absence of neoplastic diseases at treated site

Exclusion criteria

Exclusion Criteria:

  • previous surgery or pseudoparalysis on study shoulder
  • complete subscapularis deficiency
  • external rotation lag signs
  • avascular necrosis
  • post-infectious arthritis
  • proximal humerus fracture
  • inflammatory arithritis
  • axillary nerve palsy
  • concomitant tendon transfer
  • neuromuscular disorder
  • unable to speak/read English

Intra-operative Exclusion:

-tendon is NOT amenable to partial or complete repair

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    Subacromial spacer implantation

    Procedure: Subacromial spacer implantation

  • Active comparator
    Rotator Cuff Repair

    Procedure: Rotator cuff repair

Interventions

  • ProcedureSubacromial spacer implantation

    A biodegradable balloon implanted arthroscopically between the acromion and humeral head with tenotomy of long head of biceps.

  • ProcedureRotator cuff repair

    Rotator cuff repair with tenotomy of long head of biceps.

06

What researchers measure

Primary outcomes

  1. Study feasibility - randomized

    Percentage of patients randomized

    Time frame: 1 year

  2. Study feasibility - recruitment

    Number of screened patients and proportion that are deemed eligible that consent

    Time frame: 1 year

  3. Study feasibility - surgery

    Consensus among surgeon co-investigators regarding the standardized peri-operative orders and surgical techniques.

    Time frame: 1 year

Secondary outcomes

  1. ASES Score

    The ASES is a patient-reported upper extremity-specific functional assessment tool and is scored out of a maximum 100 points, where 100 represents maximum function and no pain (Richards et al., 1994). It has a pain component measured on a visual analog scale as well as ten Likert-scale questions on function (e.g., put on a coat, sleep on affected side). The ASES is reliable and is validated for this population and is one of the most commonly used shoulder outcomes in North America.

    Time frame: Baseline, pre-operative

  2. ASES Score

    The ASES is a patient-reported upper extremity-specific functional assessment tool and is scored out of a maximum 100 points, where 100 represents maximum function and no pain (Richards et al., 1994). It has a pain component measured on a visual analog scale as well as ten Likert-scale questions on function (e.g., put on a coat, sleep on affected side). The ASES is reliable and is validated for this population and is one of the most commonly used shoulder outcomes in North America

    Time frame: 3 Months, post-operative

  3. ASES Score

    The ASES is a patient-reported upper extremity-specific functional assessment tool and is scored out of a maximum 100 points, where 100 represents maximum function and no pain (Richards et al., 1994). It has a pain component measured on a visual analog scale as well as ten Likert-scale questions on function (e.g., put on a coat, sleep on affected side). The ASES is reliable and is validated for this population and is one of the most commonly used shoulder outcomes in North America

    Time frame: 6 Months, post-operative

  4. ASES Score

    The ASES is a patient-reported upper extremity-specific functional assessment tool and is scored out of a maximum 100 points, where 100 represents maximum function and no pain (Richards et al., 1994). It has a pain component measured on a visual analog scale as well as ten Likert-scale questions on function (e.g., put on a coat, sleep on affected side). The ASES is reliable and is validated for this population and is one of the most commonly used shoulder outcomes in North America

    Time frame: 12 Months, post-operative

  5. ASES Score

    The ASES is a patient-reported upper extremity-specific functional assessment tool and is scored out of a maximum 100 points, where 100 represents maximum function and no pain (Richards et al., 1994). It has a pain component measured on a visual analog scale as well as ten Likert-scale questions on function (e.g., put on a coat, sleep on affected side). The ASES is reliable and is validated for this population and is one of the most commonly used shoulder outcomes in North America

    Time frame: 24 Months, post-operative

  6. EQ5D-3L

    The EQ-5D is valid, reliable, responsive PROM used to document overall wellness based on 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression (Herdman et al., 2011). A single value is calculated (the value index), which indicates how good or bad a patient's health state is relative to a specified population. There are two components, VAS for general health, with 0 minimum and 100 maximum, with higher scores being more positive. The second component is a 25 point scale with minimum 5 and maximum 25 wit h lower scores more positive.

    Time frame: Baseline, pre-operative

  7. EQ5D-3L

    The EQ-5D is valid, reliable, responsive PROM used to document overall wellness based on 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression (Herdman et al., 2011). A single value is calculated (the value index), which indicates how good or bad a patient's health state is relative to a specified population. There are two components, VAS for general health, with 0 minimum and 100 maximum, with higher scores being more positive. The second component is a 25 point scale with minimum 5 and maximum 25 wit h lower scores more positive.

    Time frame: 3 Months, post-operative

  8. EQ5D-3L

    The EQ-5D is valid, reliable, responsive PROM used to document overall wellness based on 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression (Herdman et al., 2011). A single value is calculated (the value index), which indicates how good or bad a patient's health state is relative to a specified population. There are two components, VAS for general health, with 0 minimum and 100 maximum, with higher scores being more positive. The second component is a 25 point scale with minimum 5 and maximum 25 wit h lower scores more positive.

    Time frame: 6 Months, post-operative

  9. EQ5D-3L

    The EQ-5D is valid, reliable, responsive PROM used to document overall wellness based on 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression (Herdman et al., 2011). A single value is calculated (the value index), which indicates how good or bad a patient's health state is relative to a specified population. There are two components, VAS for general health, with 0 minimum and 100 maximum, with higher scores being more positive. The second component is a 25 point scale with minimum 5 and maximum 25 wit h lower scores more positive.

    Time frame: 12 Months, post-operative

  10. EQ5D-3L

    The EQ-5D is valid, reliable, responsive PROM used to document overall wellness based on 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression (Herdman et al., 2011). A single value is calculated (the value index), which indicates how good or bad a patient's health state is relative to a specified population. There are two components, VAS for general health, with 0 minimum and 100 maximum, with higher scores being more positive. The second component is a 25 point scale with minimum 5 and maximum 25 wit h lower scores more positive.

    Time frame: 24 Months, post-operative

  11. SANE Score

    The Single Assessment Numeric Evaluation (SANE) score is a single question that asks patients to rate their affected shoulder as a percentage of normal to provide a simple and efficient measure of patient outcome (Gowd et al., 2019). Patients will be asked the following question: "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"

    Time frame: Baseline, pre-operative

  12. SANE Score

    The Single Assessment Numeric Evaluation (SANE) score is a single question that asks patients to rate their affected shoulder as a percentage of normal to provide a simple and efficient measure of patient outcome (Gowd et al., 2019). Patients will be asked the following question: "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"

    Time frame: 3 Months, post-operative

  13. SANE Score

    The Single Assessment Numeric Evaluation (SANE) score is a single question that asks patients to rate their affected shoulder as a percentage of normal to provide a simple and efficient measure of patient outcome (Gowd et al., 2019). Patients will be asked the following question: "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"

    Time frame: 6 Months, post-operative

  14. SANE Score

    The Single Assessment Numeric Evaluation (SANE) score is a single question that asks patients to rate their affected shoulder as a percentage of normal to provide a simple and efficient measure of patient outcome (Gowd et al., 2019). Patients will be asked the following question: "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"

    Time frame: 12 Months, post-operative

  15. SANE Score

    The Single Assessment Numeric Evaluation (SANE) score is a single question that asks patients to rate their affected shoulder as a percentage of normal to provide a simple and efficient measure of patient outcome (Gowd et al., 2019). Patients will be asked the following question: "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"

    Time frame: 24 Months, post-operative

  16. Constant Score

    The Constant Score is validated and reliable PROM/clinical tool used to evaluate overall shoulder function based on pain, activities of daily living, and the clinical evaluation of ROM and strength (Constant \& Murley, 1987). This score is widely reported in European-based literature. Minimum value is 0 and maximum value is 100, with higher scores being a better outcome.

    Time frame: Baseline, pre-operative

  17. Constant Score

    The Constant Score is validated and reliable PROM/clinical tool used to evaluate overall shoulder function based on pain, activities of daily living, and the clinical evaluation of ROM and strength (Constant \& Murley, 1987). This score is widely reported in European-based literature. Minimum value is 0 and maximum value is 100, with higher scores being a better outcome.

    Time frame: 3 Months, post-operative

  18. Constant Score

    The Constant Score is validated and reliable PROM/clinical tool used to evaluate overall shoulder function based on pain, activities of daily living, and the clinical evaluation of ROM and strength (Constant \& Murley, 1987). This score is widely reported in European-based literature. Minimum value is 0 and maximum value is 100, with higher scores being a better outcome.

    Time frame: 6 Months, post-operative

  19. Constant Score

    The Constant Score is validated and reliable PROM/clinical tool used to evaluate overall shoulder function based on pain, activities of daily living, and the clinical evaluation of ROM and strength (Constant \& Murley, 1987). This score is widely reported in European-based literature. Minimum value is 0 and maximum value is 100, with higher scores being a better outcome.

    Time frame: 12 Months, post-operative

  20. Constant Score

    The Constant Score is validated and reliable PROM/clinical tool used to evaluate overall shoulder function based on pain, activities of daily living, and the clinical evaluation of ROM and strength (Constant \& Murley, 1987). This score is widely reported in European-based literature. Minimum value is 0 and maximum value is 100, with higher scores being a better outcome.

    Time frame: 24 Months, post-operative

  21. Range of Motion

    For both shoulders, forward flexion and external rotation at 0 and 90 degrees abduction will be measured with a goniometer and reported in degrees.

    Time frame: Baseline, pre-operative

  22. Range of Motion

    For both shoulders, forward flexion and external rotation at 0 and 90 degrees abduction will be measured with a goniometer and reported in degrees.

    Time frame: 3 Months, post-oeprative

  23. Range of Motion

    For both shoulders, forward flexion and external rotation at 0 and 90 degrees abduction will be measured with a goniometer and reported in degrees.

    Time frame: 6 Months, post-operative

  24. Range of Motion

    For both shoulders, forward flexion and external rotation at 0 and 90 degrees abduction will be measured with a goniometer and reported in degrees.

    Time frame: 12 Months, post-operative

  25. Range of Motion

    For both shoulders, forward flexion and external rotation at 0 and 90 degrees abduction will be measured with a goniometer and reported in degrees.

    Time frame: 24 Months, post-oeprative

  26. Isometric Strength

    Measured using a hand-held dynamometer, in flexion, abduction, and external rotation.

    Time frame: Baseline, pre-operative

  27. Isometric Strength

    Measured using a hand-held dynamometer, in flexion, abduction, and external rotation.

    Time frame: 3 Months, post-operative

  28. Isometric Strength

    Measured using a hand-held dynamometer, in flexion, abduction, and external rotation.

    Time frame: 6 Months, post-operative

  29. Isometric Strength

    Measured using a hand-held dynamometer, in flexion, abduction, and external rotation.

    Time frame: 12 Months, post-operative

  30. Isometric Strength

    Measured using a hand-held dynamometer, in flexion, abduction, and external rotation.

    Time frame: 24 Months, post-operative

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05788250
Lead sponsor
Panam Clinic
Responsible party
Sponsor
First posted
Mar 28, 2023
Start date
Aug 2024 (estimated)
Primary completion
Oct 2026 (estimated)
Completion
Oct 2027 (estimated)
Last update
Apr 2, 2024

Study contacts

Sheila McRae, PhD
Contact
smcrae@panamclinic.com
204-925-7469
Brenna Cyr, BKin
Contact
bcyr@panamclinic.com
204-927-2828
Jarret Woodmass, MD
principal investigator · Pan Am Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion